Elisa has expertise in generating organoid lines and complex cancer microtissues in vitro from multiple primary human cell sources, including stromal cells, tumor cells and tumour-infiltrating lymphocytes. In the past, she has used these microtissues for phenotypic characterisation and drug testing. Elisa’s research at the IHB focuses on identifying comprehensive strategies for generating primary tumour explant models with sufficient longevity to have utility as predictive screening platforms for immuno-oncology applications and to answer fundamental questions in tumour biology.
